The First One

The National Center for Advancing Translational Sciences is embarking on its first clinical trial, reports the Nature News Blog. The trial is examining a drug, called DEX-M74, for hereditary inclusion body myopathy, a condition that strikes young adults and for which there is no treatment, a press release adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.